FDA Inspection 960829 — SpineFrontier, Inc.

SpineFrontier, Inc. — FEI 3005977257

The FDA completed an inspection of SpineFrontier, Inc. on February 10, 2016 in Burlington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 10, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Burlington, MA (United States)